Interest in stocks with direct and indirect exposure to the "vaccine trade" is through the roof. And with this interest comes some wild price action in both directions.
Today's play is in one of those names, but we like it more for its chart action than anything else. (It's kinda what we do here) ;)
Something we’ve been working on internally this year is using various bottoms-up tools and scans to complement our top-down approach. One way we’re doing this is by identifying stocks as they climb the market-cap ladder from small, to mid, to large, and ultimately to mega-cap status (over $200B).
Once they graduate from small-cap to mid-cap status (over $2B) they come on our radar. Likewise, when they surpass the roughly $30B mark, they roll off our list.
But the scan doesn’t just end there. We only want to look at the strongest growth industries in the market as that is typically where these potential 50-baggers come from.
For those new to this exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or relative basis. Maybe it’s a custom index or inverted, who knows!
We do all this to put aside the biases we have associated with this specific security/the market and come to a conclusion based solely on price.
You can guess what it is if you must, but the real value comes from sharing what you would do right now. Buy, Sell, or Do Nothing?
At the beginning of each week, we publish performance tables for a variety of different asset classes and categories along with commentary on each.
Looking at the past helps put the future into context. In this post, we review the relative strength trends at play and preview some of the things we’re watching in order to profit in the weeks and months ahead.
We've explained how we continue to see the weight of the evidence shifting in favor of the bulls with each passing week.
We can finally say we're no longer in a split market environment. Instead, we see a market supported by strong internals where the bias is clearly higher for equities and risk-assets alike.
After the prior week's resurgence from the Tech/Growth trade, as well as new highs from many of the major sectors and indexes, this week showed a strong rotation back into cyclical groups.
